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ttp://dx.doi.org/10.1016/j.ajpath.2013.10.016Renin is a newly discovered constituent of mast cells. Given that mast cells play a major role in IgE-
mediated allergic hypersensitivity, we investigated whether activation of the high-afﬁnity IgE receptor
FcεRI elicits release ofmast-cell renin. Cross-linking of FcεRI on the surface of mature bonemarrowederived
mast cells elicited release of enzymatically active renin protein. The angiotensin Ieforming activity
of the renin protein was completely blocked by the selective renin inhibitor BILA 2157, which
excludes formation of angiotensin I by proteases other than renin. FcεRI-mediated mast-cell renin
release was inhibited by dexamethasone and potentiated by the proinﬂammatory mediator PGE2.
Furthermore, cross-linking of mast-cell FcεRI in ex vivo murine hearts passively sensitized with
monoclonal anti-DNP IgE also resulted in mast-cell degranulation and overﬂow of renin. Our ﬁnd-
ings indicate that IgE-mediated allergic hypersensitivity provokes release of renin from both
cultured and resident cardiac mast cells, a process likely to be exacerbated in a chronic inﬂam-
matory background. Given the widespread distribution of mast cells, and the presence of angio-
tensinogen and angiotensin-converting enzyme in many tissues, renin release in immediate
hypersensitivity reactions could result in local angiotensin II generation and multiorgan dysfunc-
tions. (Am J Pathol 2014, 184: 376e381; http://dx.doi.org/10.1016/j.ajpath.2013.10.016)Supported in part by the NIH (grants R01HL034215 and R37HL47073
to R.L.), the American Heart Association (grant-in-aid 11GRNT5600025 to
R.L.), and scientist development (grant 11SDG5710010 to A.D.L.) and the
Caja Madrid Foundation (P.A.R.).Mast cells (MCs) express and secrete active renin.1e3 MCs
are known to play a major role in IgE-mediated allergic re-
actions.4,5 Whether immediate hypersensitivity can elicit MC
renin release is a question of major basic and translational
importance, given the ubiquitous presence of MCs3,6,7 and
the multiplicity of angiotensin-induced organ dysfunctions.8
To address this question, we used murine bone mar-
rowederived MCs (BMMCs) and MCs in ex vivo murine
hearts. Here, we report the novel ﬁnding that speciﬁc cross-
linking of the high-afﬁnity FcεRI receptor on the surface of
BMMCs and heart MCs elicits the release of enzymatically
active renin protein. This process is inhibited by glucocorti-
coids and is enhanced by PGE2. Similarly, cross-linking of
MC FcεRI in ex vivo murine hearts resulted in MC degran-
ulation and overﬂow of renin.
Materials and Methods
Isolation of Murine BMMCs
BMMCs were cultured as described previously.9 In brief,
bone marrow was obtained from femurs and tibias of C57BL/
6J mice euthanized by cervical dislocation under light CO2stigative Pathology.
.anesthesia as approved by the Weill Cornell Medical College
Institutional Animal Care and Use Committee. Bone marrow
cells were cultured in RPMI 1640 medium (Life Technolo-
gies, Carlsbad, CA) containing 10 U/mL antibiotics (pen-
icillinestreptomycin), 10% heat-inactivated fetal calf serum,
55 mmol/L 2-mercaptoethanol, and 20 ng/mL each recombi-
nant murine IL-3 and stem cell factor (SCF) (PeproTech,
Rocky Hill, NJ). Bone marrow cells were counted and placed
in culture at a cell density of 0.5 106 cells/mL. Cell medium
was changed every 3 to 4 days, and nonadherent cells were
transferred to a new ﬂask. Mature BMMCs obtained after 4
weeks of culture stained positive for Toluidine Blue; more-
over, >90% of cells expressed both c-Kit and FcεRI. All
experiments were performed with BMMCs cultured for 4 to 7
weeks. Cells were plated on coverslips and incubated in
0.05% Toluidine Blue (Sigma-Aldrich, St. Louis, MO) for 10
minutes at 37C. Cells were then ﬁxed with 4% para-
formaldehyde for 15 minutes at room temperature. Coverslips
Figure 1 Granular staining and expression of c-Kit, FcεRI, and renin in
BMMCs. A: Characteristic Toluidine Blueestained murine bone marrow cells
at isolation and differentiated BMMCs after 5 weeks in culture with IL-3 and
SCF. B: Fluorescence-activated cell-sorting analysis shows c-Kit-PE and
FcεRIeﬂuorescein isothiocyanate coexpression (>90%) on the BMMC sur-
face after 5 weeks in culture. C: Representative Western blots with anti-
mouse renin antibody show a renin-positive band in total protein lysate
(50 mg/lane) of BMMCs (5-week culture) and KNRK rat kidney cells used as
positive control (left lanes) and lack of immunoreactive bands after direct
incubation of total BMMC and KNRK lysates with the secondary antibody
(right lanes). D: Representative Western blots of total lysates isolated from
BMMCs at 1, 3, 4, and 5 weeks (w) in culture. Scale bars: 5 mm (A). BMC,
bone marrow cells; FITC, ﬂuorescein isothiocyanate; PE, phycoerythrin.
FcεRI-Mediated Mast-Cell Renin Releasewere mounted on glass slides using VectaMount medium
(Vector Laboratories, Burlingame, CA) and were examined
under an Eclipse 80i microscope (Nikon Instruments, Mel-
ville, NY).
Flow Cytometry
To assess the expression of c-Kit and FcεRI on BMMC
cell surface, aliquots of cells cultured for 5 weeks were
centrifuged and incubated for 10 minutes with PBS (Sigma-
Aldrich) containing 0.1% bovine serum albumin and puri-
ﬁed rat anti-mouse CD16/CD32 (Fc Block; BD Biosciences,
San Jose, CA) on ice. At the end of the incubation, ﬂuo-
rescein isothiocyanateeconjugated monoclonal anti-mouse
FcεRI (eBioscience, San Diego, CA) and phycoerythrin-
conjugated monoclonal anti-mouse CD117 (c-Kit; BD
Biosciences) were added to the cells for 30 minutes on ice.
After a PBS washing, labeled cells were analyzed with a BD
LSR II ﬂow cytometer (BD Biosciences).
Western Blotting
BMMCs were lysed using radioimmunoprecipitation assay
buffer (Sigma-Aldrich). KNRK rat kidney cell lysate was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
BMMC and KNRK samples for electrophoresis (50 mg/lane)
and Western blotting were prepared as described previously.10
Polyvinylidene diﬂuoride membranes were probed with anti-
mouse renin (Santa Cruz) at a dilution of 1:500. Anti-goat IgG
horseradish peroxidase (HRP)elinked secondary antibody
(EMDMillipore, Billerica, MA) was used at a 1:5000 dilution.
Antieb-actin HRP-conjugated antibody (Alpha Diagnostic In-
ternational, San Antonio, TX) was used at a 1:30,000 dilution.
Proteins of interest were detected using Immobilon Western
chemiluminescent HRP substrate (EMDMillipore).
FcεRI-Mediated BMMC Degranulation
In brief, after 16 hours of sensitization with 0.125 mg/mL anti-
DNP IgE (Sigma-Aldrich), 1 105 BMMCs per sample were
washed and resuspended inRinger’s buffer (pH7.4). Equal cell
volumes were aliquoted in 96 wells and challenged with 10
ng/mL antigen [dinitrophenylated human serum albumin
(DNP-HSA)] for 20minutes at 37C in the absence or presence
of 1 mmol/L PGE2 (R&D Systems, Minneapolis, MN). Other
cellswere preincubatedwith 2 nmol/L dexamethasone (Sigma-
Aldrich) for 5 minutes before antigen challenge. When MC
activators were used, cells were incubated with 1 mmol/L
A23187calcium ionophore, 300mg/mLcompound48/80 (c48/
80), or 1mmol/LATP (all fromSigma-Aldrich) for 20minutes
at 37C. At the end of the incubation, samples were placed on
ice and centrifuged at 300 g for 5minutes. Supernatantswere
collected and used to measure the b-hexosaminidase (b-HEX)
release. Cell pellets were lysed with 0.5% Triton X-100, and
total lysates were used to determine total b-HEX content. b-
HEX release was expressed as the percentage ratio betweenThe American Journal of Pathology - ajp.amjpathol.orgsupernatant and totalb-HEX (where totalb-HEX is equal to the
sum of b-HEX content in supernatant and total lysate).
Measurement of b-HEX
b-HEX was measured as described previously.11 Samples of
BMMC supernatants, total lysates, and coronary overﬂow (20
mL) were placed in 96-well plates. Substrate solution (50 mL;
p-nitrophenyl-N-acetyl-b-D-glucosaminide, 1.3 mg/mL in 0.1
mol/L citrate buffer, pH 4.5) were added to each well and
incubated for 90minutes at 37C. The reaction was stopped by
adding 150 mL of 0.2 mol/L glycine (pH 10.7). Optical density
was read at 405 nm on a spectrophotometric plate reader using
SoftMax Pro version 4.8 (MolecularDevices, Sunnyvale, CA).
Measurement of Histamine
Histamine released from BMMCs was measured using an
enzyme immunoassay kit, according to the manufacturer’s377
Figure 2 Classical MC activators elicit degranulation and release of histamine and renin from mature BMMCs. BMMCs were incubated for 20 minutes at 37C
with A23187 (1 mmol/L), c48/80 (300 mg/mL), or ATP (1 mmol/L). AeC: Release of b-HEX (A), histamine (B), and renin protein (C). Percentages represent the
percent ratio between supernatant and total b-HEX or histamine. D: Renin activity as affected by the three MC activators in the absence or presence of the
renin inhibitor BILA (100 nmol/L) was measured in BMMC supernatant in terms of angiotensin I (Ang I) formation (mg/hour per mg of total protein). Data are
expressed as means  SEM. Number of experiments (left to right): nZ 10, 7, 6, and 10 (A); nZ 7, 14, 5, and 6 (B); nZ 4, 5, 4, and 7 (C); and nZ 6, 5, 8,
4, 3, 13, and 6 (D). *P < 0.05, **P < 0.01, and ***P < 0.001 versus control. yP < 0.01, yyP < 0.001 versus absence of BILA.
Aldi et alinstructions (Beckman Coulter, Brea, CA). In brief, after
stimulation, supernatants and total lysates were collected
from BMMCs as described above for the b-HEX assay.
Absorbance was read in a microplate reader (Molecular
Devices, Sunnyvale, CA) at 405 nm, and histamine levels
were determined by comparison with a calibration curve.
Histamine release was expressed as the percent ratio be-
tween supernatant and total histamine.
Measurement of Renin Protein
Mouse renin 1 was measured in BMMC supernatants using
an enzyme-linked immunosorbent assay kit (RayBiotech,
Norcross, GA) according to the manufacturer’s instructions.
In brief, 3  105 BMMCs were stimulated as described
above for the b-HEX assay, and 100 mL from each super-
natant was added to wells coated with anti-mouse renin 1
and incubated for 16 hours at 4C. Absorbance was read in a
microplate reader (Molecular Devices, Sunnyvale, CA) at
450 nm, and the renin protein concentration was calculated
by comparison with a standard curve.Figure 3 FcεRI aggregation elicits the release of renin from BMMCs, modulated
with murine anti-DNP IgE and then were challenged with DNP-HSA antigen for 20 mi
mmol/L PGE2. In D, in the absence or presence of 100 nmol/L BILA to assess renin-i
percentages represent the percent ratio between supernatant and total b-HEX or hi
alone or with antigen and BILA, Dex, or PGE2. Data are expressed asmeans SEM. Nu
9 (B); nZ 4, 4, 5, and 4 (C); and nZ 16, 12, 3, 6, and 6 (D). **P< 0.01; ***P< 0.00
378Measurement of Renin Activity
Renin activity was measured, as described previously,11 in
supernatants from BMMCs (treated as described above) using
a radioimmunoassay kit (DiaSorin, Stillwater, MN; Saluggia,
Italy), according to the manufacturer’s instructions. Porcine
angiotensinogen substrate (Sigma-Aldrich) was added to the
supernatants. The reaction for angiotensin I production was
conducted for 1.5 hours in the presence or absence of 100
nmol/L of the highly selective renin inhibitor BILA 2157
(BILA).2,12 Total protein concentration was measured using a
DC protein assay kit (Bio-Rad Laboratories, Hercules, CA).
Results were normalized to total protein.
Perfusion of Mouse Hearts ex Vivo
Seven C57BL/6J male mice, 10 to 12 weeks old (Jackson
Laboratory, Bar Harbor, ME), were passively sensitized with
an intraperitoneal injection of murine anti-DNP IgE (6 mg/200
mL PBS; Sigma-Aldrich). Three other mice (nonsensitized
controls) received an intraperitoneal injection of PBS alone.by dexamethasone (Dex) and PGE2. AeD: BMMCs were sensitized for 16 hours
nutes at 37C in the presence or absence of 2 nmol/L dexamethasone (Dex), 1
nduced angiotensin I formation. For release of b-HEX (A) and histamine (B),
stamine. Renin activity (D) was measured in BMMC supernatant with antigen
mber of experiments (left to right): nZ 8, 21, 8, and 9 (A); nZ 8, 21, 18, and
1 versus control (IgE). yP< 0.05, yyP< 0.01, and yyyP< 0.001 versus antigen.
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Figure 4 FcεRI cross-linking on tissue-resident MCs elicits the release of
renin from ex vivo mouse hearts. Time course of overﬂow of active renin
(indicative of angiotensin I formation) (A), histamine (B), andb-HEX (marker of
MC degranulation) (C) from Langendorff-perfused murine hearts. Mice were
passively sensitized in vivo with 6 mg of murine monoclonal anti-DNP IgE; 24
hours later, hearts were excised and challenged with 200 mg of DNP-HSA.
Overﬂow fractions were collected every 2 minutes after antigen injection. Data
are expressed as means  SEM. nZ 5 to 7 hearts. *P < 0.05 versus coronary
efﬂuent preceding antigen, unpaired t-test. OD, optical density at 405 nm.
FcεRI-Mediated Mast-Cell Renin ReleaseTwenty-four hours later, all mice were intraperitoneally injec-
tedwith 100 IUheparin, anesthetizedwithCO2, and euthanized
by cervical dislocation as approved by the Weill Cornell
Medical College Institutional Animal Care and Use Commit-
tee. The isolated hearts were transferred to a Langendorff
apparatus (Radnoti, Monrovia, CA). The aorta was cannulated
with a ﬂanged 20-gauge stainless steel needle. The heart was
perfused through the aorta in a retrograde mode at a constant
pressure of 100 cmH2OwithmodiﬁedKrebseHenseleit buffer
containing (mmol/L) NaCl, 120; KCl, 4.7; CaCl2, 2.5;MgSO4,
1.2; KH2PO4, 1.2; NaHCO3, 25; glucose, 11; pyruvic acid, 2;
and EDTA, 0.5. The perfusion ﬂuid was bubbled with 95%
O2e5%CO2 at 37C, to achieve a pH of 7.4. After a 20-minute
equilibration period, hearts were challenged with antigen
(rapid intra-aortic injection of 200 mg DNP-HSA in 300 mL
KrebseHenseleit buffer). Samples of coronary ﬂow efﬂuent
were collected every 2 minutes. The samples were assayed for
b-HEX, renin activity, and histamine. For the b-HEX mea-
surements, samplesof coronary efﬂuentwere concentrated8- to
10-fold by centrifugal ﬁltration (EMDMillipore).
Statistical Analysis
Unpaired t-test was used throughout the study. P < 0.05
was considered statistically signiﬁcant. Data are expressed
as means  SEM.
Results
Renin Is Expressed in BMMCs
Murine bone marrow cells matured into typical MCs on
in vitro culture with SCF and IL-3 for 5 weeks, at which
point they exhibited the classical Toluidine-Blue granular
staining, were double-positive (>90%) for the FcεRI and
c-Kit receptors, and contained renin protein (Figure 1).
Notably, renin protein was present in bone marrow cells at
the time of their isolation and continued to be present during
the differentiation phase (Figure 1).
BMMC Renin Release by Classical Degranulating Agents
Exposure of BMMCs to canonical degranulating agents (1
mmol/L Ca2þ ionophore A23187,13 c48/80,14 and 1 mmol/L
ATP15) elicited degranulation (approximately ﬁvefold to
eightfold increase in b-HEX release, relative to control), and
release of histamine (approximately 7- to 13-fold increase) and
renin protein (approximately 2- to 25-fold increase) (Figure 2).
Released renin was enzymatically active, because it cleaved
angiotensin I from angiotensinogen (approximately 5- to 14-
fold increase in angiotensin I formed, relative to control)
(Figure 2D). Notably, the formation of angiotensin I in the
supernatant of MCs incubated with A23187, c48/80, or ATP
or subjected to FcεRI aggregation was prevented by 100
nmol/L of the highly selective renin inhibitor BILA (Figures 2
and 3),1,2,12 which demonstrates that proteases other than
renin were not involved in the formation of angiotensin I.The American Journal of Pathology - ajp.amjpathol.orgBMMC Renin Release by FcεRI Cross-Linking
After passive sensitization of BMMCs with murine anti-DNP
IgE, challenge with DNP-HSA also caused degranulation
(approximately fourfold increase in b-HEX release, relative
to control), release of histamine (approximately 2.5-fold in-
crease), and release of renin protein (approximately threefold
increase), as well as an increase in angiotensin Ieforming
activity (approximately fourfold increase) (Figure 3).
Given that anti-inﬂammatory glucocorticoids are known to
prevent IgE-mediated MC degranulation,17 we assessed
whether they also modulate MC renin release. When IgE-
sensitized MCs were challenged with speciﬁc antigen in the
presence of 2 nmol/L dexamethasone, b-HEX and histamine
release were reduced by approximately 50% to 60%, whereas379
Aldi et althe release of renin protein and angiotensin Ieforming activity
decreased by approximately 40% and 60%, respectively
(Figure 3).
PGE2 is known to modulate FcεRI-mediated MC activa-
tion.18 We therefore assessed whether this eicosanoid also
modulates MC renin release. When IgE-sensitized MCs were
challengedwith the speciﬁc antigen in the presence of 1 mmol/L
PGE2, the release of b-HEX, histamine, renin protein, and
angiotensin Ieforming activity increased approximately four-
fold, 2.5-fold, 30%, and ﬁvefold, respectively (Figure 3). This
suggests that MC renin release and consequent RAS activation
can be magniﬁed in the course of inﬂammatory responses in
which PGE2 is copiously produced.
19
FcεRI Cross-Linking Induces Renin Release from
Resident Tissue MCs
We next asked whether resident tissue MCs also release
renin after FcεRI cross-linking. We used Langendorff-
perfused hearts excised from mice passively sensitized
with monoclonal anti-DNP IgE. Antigen challenge of these
hearts resulted in substantial resident MC degranulation, as
demonstrated by a marked increase in the coronary overﬂow
of b-HEX, histamine, and renin activity in the ﬁrst 2
minutes after antigen challenge (two-, four-, and threefold
increase, respectively) (Figure 4). Notably, no release of
b-HEX or histamine and no renin activity occurred after
antigen challenge of hearts from control nonsensitized mice.
Discussion
Here, we report the novel ﬁnding that cross-linking of
FcεRI-bound IgE antibodies on the surface of BMMCs and
tissue-resident MCs elicits the release of enzymatically
active renin protein. This process is inhibited by glucocor-
ticoids and is enhanced by the proinﬂammatory mediator
PGE2. To our knowledge, this is the ﬁrst time that FcεRI
aggregation has been shown to elicit MC renin release.
The calcium ionophore A2318713 was an effective elicitor
of renin release from BMMCs, suggesting that activation of
Ca2þ inﬂux and phospholipase Cedependent mobilization
of Ca2þ from intracellular stores20 play a role in MC renin
release. Given that an increase in intracellular calcium in-
hibits renin release from juxtaglomerular cells,21 different
mechanisms must control renin secretion in MCs and in the
juxtaglomerular apparatus. The ﬁnding that c48/80 induced
release of MC renin, together with b-HEX and histamine,
suggests the presence of renin in extrudable granular for-
mations, analogous to mastocytoma cells stimulated with
c48/80 or substance P.1,16 Indeed, typical MC degranulation
requires the expulsion of membrane-free granules from an
intact cell capable of repeated degranulation,14 as we have
previously observed in mastocytoma cells repeatedly stim-
ulated to release renin with c48/80.1
Although ATP is known to elicit MC degranulation,15 the
present study is the ﬁrst to show that ATP promotes the380release of active renin from MCs. This novel ﬁnding is of
particular cardiovascular relevance, because sympathetic
purinergic nerve terminals release ATP in close proximity to
MCs,1,22 likely promoting renin release.
Dexamethasone inhibited FcεRI-induced MC degranula-
tion and, most importantly, it also decreased renin release. A
dexamethasone-induced decrease in MC degranulation has
been attributed to reduced FcεRI expression on the MC
surface,23 and it is reported that dexamethasone diminishes
MC degranulation and cytokine production by suppressing
FcεRI-induced activation of PI3-kinase.24 Furthermore,
nongenomic mechanisms have been invoked in the rapid
glucocorticoid-induced inhibition of IgE-mediated MC
degranulation and histamine release in a guinea-pig asthma
model in vivo and in the RBL-2H3 MC line in vitro. These
effects were mediated by a suppression of the increase in
intracellular Ca2þ that characterizes MC degranulation.25
The PGE2-induced potentiation suggests that MC renin
release and consequent RAS activation can be magniﬁed in
the course of inﬂammatory responses in which PGE2 is
copiously produced.19 Given the pervasiveness of PGE2
production in inﬂammatory reactions,26 and also the PGE2-
induced potentiation of renin release from BMMCs, PGE2
can be envisioned as a major player in the activation of local
RAS in various organs.
In conclusion, we found that FcεRI cross-linking on
BMMCs and tissue-resident MCs elicits the release of enzy-
matically active renin protein. The angiotensin Ieforming
activity of the renin protein was completely blocked by the
highly selective renin inhibitor BILA, a ﬁnding that excludes
involvement of other proteases in the formation of angiotensin
I. The ﬁnding that MC renin release was mimicked by ca-
nonical degranulators such as calcium ionophore and c48/80
suggests that MC renin may be stored in granules and that its
release may depend on an increase in intracellular Ca2þ. Our
present ﬁndings indicate that IgE-mediated allergic hyper-
sensitivity provokes the release of MC renin, which is poten-
tiated by PGE2 and inhibited by dexamethasone. Given the
ubiquitous presence of MCs,3,6,7 and the presence of angio-
tensinogen and angiotensin-converting enzyme in many tis-
sues,27 renin release in allergic hypersensitivity reactions
could result in local angiotensin II formation and angiotensin
IIemediated multiorgan dysfunctions, a process likely exac-
erbated in an inﬂammatory background.
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